956,632 Shares in Kenvue Inc. $KVUE Acquired by Aquatic Capital Management LLC

Key Points

• Aquatic Capital Management LLC bought a new stake of 956,632 shares of Kenvue in Q3, valued at about $15.53 million according to its 13F filing.
• Analysts hold a consensus Hold rating on KVUE with a $19.58 price target after several firms recently raised targets to the $18–$20 range; three analysts rate it Buy while thirteen rate it Hold.
• Kenvue pays a quarterly dividend that annualizes to a 4.7% yield, but its payout ratio is 107.79% and roughly 97.64% of shares are institutionally owned, signaling potential dividend sustainability concerns.

Aquatic Capital Management LLC bought a new stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 956,632 shares of the company's stock, valued at approximately $15,526,000.

Several other institutional investors have also added to or reduced their stakes in KVUE. Cornerstone Planning Group LLC increased its stake in shares of Kenvue by 705.2% in the 3rd quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company's stock worth $25,000 after purchasing an additional 1,361 shares in the last quarter. NBT Bank N A NY increased its position in Kenvue by 180.3% in the third quarter. NBT Bank N A NY now owns 1,564 shares of the company's stock worth $25,000 after buying an additional 1,006 shares in the last quarter. Salomon & Ludwin LLC bought a new position in shares of Kenvue in the third quarter worth about $25,000. Golden State Wealth Management LLC lifted its position in shares of Kenvue by 150.1% during the 3rd quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company's stock valued at $32,000 after buying an additional 1,190 shares in the last quarter. Finally, Trust Co. of Vermont lifted its position in shares of Kenvue by 50.9% during the 3rd quarter. Trust Co. of Vermont now owns 2,385 shares of the company's stock valued at $39,000 after buying an additional 804 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have commented on KVUE shares. UBS Group raised their target price on shares of Kenvue from $17.00 to $19.00 and gave the stock a "neutral" rating in a research note on Wednesday, February 18th. Barclays increased their price target on Kenvue from $18.00 to $19.00 and gave the stock an "equal weight" rating in a research note on Friday, March 6th. Canaccord Genuity Group boosted their price objective on Kenvue from $17.00 to $18.00 and gave the company a "hold" rating in a research report on Wednesday, February 18th. Zacks Research raised Kenvue from a "strong sell" rating to a "hold" rating in a research note on Wednesday, November 26th. Finally, Citigroup increased their target price on Kenvue from $18.00 to $20.00 and gave the stock a "neutral" rating in a research report on Wednesday, February 18th. Three equities research analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company's stock. Based on data from MarketBeat.com, Kenvue presently has a consensus rating of "Hold" and a consensus price target of $19.58.

Kenvue Stock Performance

Shares of NYSE KVUE opened at $17.51 on Friday. The company has a market cap of $33.55 billion, a P/E ratio of 22.73, a P/E/G ratio of 3.97 and a beta of 0.51. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $25.17. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.96. The firm's fifty day moving average is $17.89 and its two-hundred day moving average is $17.30.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings data on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, beating the consensus estimate of $0.22 by $0.05. The business had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $3.68 billion. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The business's revenue was up 3.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.26 EPS. As a group, analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th were paid a $0.2075 dividend. The ex-dividend date of this dividend was Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a yield of 4.7%. Kenvue's payout ratio is presently 107.79%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.